Fusion Pharmaceuticals Inc.
FUSNDelisted Jun 5, 2024- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001805890
Fusion Pharmaceuticals Inc. was delisted on Jun 5, 2024; its insiders filed their last Form 4 on Jun 4, 2024; 114 institutions reported holding it in 13F filings for Q1 2024, worth $1.47B in total; Duquesne Family Office was the only superinvestor holding it.
13F holders, Q1 2024
Institutional positions in Fusion Pharmaceuticals Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
FUSN is no longer listed, so this page shows Q1 2024. 13F filings for later quarters list far fewer holders.
- Institutional holders
- 114
- +37 vs. Q4 2023
- Shares held
- 69.1M
- +8.29M (+13.6%) vs. Q4 2023
- Total value
- $1.47B
- +$888.9M (+152.2%) vs. Q4 2023
- New holders
- 65
- 25 more added
- Sold out
- 28
- 13 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting FUSN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 114 | $1.47B |
| Q4 2023 | 77 | $584.1M |
| Q3 2023 | 41 | $129.8M |
| Q2 2023 | 41 | $235.1M |
| Q1 2023 | 38 | $171.9M |
| Q4 2022 | 30 | $88.9M |
| Q3 2022 | 34 | $80.3M |
| Q2 2022 | 31 | $69.4M |
| Q1 2022 | 28 | $219.1M |
| Q4 2021 | 32 | $116.0M |
| Q3 2021 | 40 | $220.6M |
| Q2 2021 | 39 | $221.8M |
| Q1 2021 | 38 | $295.9M |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Fusion Pharmaceuticals Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Barclays PLC | 8,683 | $185.1K | 0.00% | +8,683 | New |
| Cutler Group LP | 8,600 | $183.0K | 0.09% | +7,500+681.8% | Added |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 5,252 | $112.0K | 0.00% | +5,252 | New |
| Signaturefd, LLC | 2,949 | $62.9K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 1,500 | $32.0K | 0.00% | −3,500−70.0% | Reduced |
| Royal Bank of Canada | 924 | $20.0K | 0.00% | −33,595−97.3% | Reduced |
| TD Waterhouse Canada Inc. | 700 | $14.9K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 508 | $10.8K | 0.00% | −2,500−83.1% | Reduced |
| Toth Financial Advisory Corp | 501 | $10.7K | 0.00% | +501 | New |
| EntryPoint Capital, LLC | 349 | $7.44K | 0.01% | +349 | New |
| Daiwa Securities Group Inc. | 268 | $6.00K | 0.00% | +268 | New |
| Advisor Group Holdings, Inc. | 86 | $1.83K | 0.00% | 00.0% | Unchanged |
| GAMMA Investing LLC | 26 | $554 | 0.00% | +26 | New |
| Scarborough Advisors, LLC | 13 | $277 | 0.00% | +13 | New |
| OrbiMed Advisors LLC | 0 | $0 | 0.00% | −3,122,770−100.0% | Sold out |
| Adams Street Partners LLC | 0 | $0 | 0.00% | −2,947,809−100.0% | Sold out |
| Artal Group S.A. | 0 | $0 | 0.00% | −1,005,500−100.0% | Sold out |
| Wellington Management Group LLP | 0 | $0 | 0.00% | −744,474−100.0% | Sold out |
| Ikarian Capital, LLC | 0 | $0 | 0.00% | −500,000−100.0% | Sold out |
| Adage Capital Partners GP, L.L.C. | 0 | $0 | 0.00% | −400,000−100.0% | Sold out |
| Jennison Associates LLC | 0 | $0 | 0.00% | −301,020−100.0% | Sold out |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −293,611−100.0% | Sold out |
| Pier Capital, LLC | 0 | $0 | 0.00% | −277,111−100.0% | Sold out |
| Woodline Partners LP | 0 | $0 | 0.00% | −222,462−100.0% | Sold out |
| UBS Oconnor LLC | 0 | $0 | 0.00% | −213,107−100.0% | Sold out |
| Weiss Multi-Strategy Advisers LLC | 0 | $0 | 0.00% | −172,357−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −153,792−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −133,550−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −86,199−100.0% | Sold out |
| Sectoral Asset Management Inc | 0 | $0 | 0.00% | −57,297−100.0% | Sold out |
| Chartwell Investment Partners, LLC | 0 | $0 | 0.00% | −49,890−100.0% | Sold out |
| Superstring Capital Management LP | 0 | $0 | 0.00% | −45,801−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −23,161−100.0% | Sold out |
| Standard Life Aberdeen plc | 0 | $0 | 0.00% | −21,697−100.0% | Sold out |
| Raymond James & Associates | 0 | $0 | 0.00% | −20,200−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −19,134−100.0% | Sold out |
| Forefront Analytics, LLC | 0 | $0 | 0.00% | −16,715−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −12,757−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −12,501−100.0% | Sold out |
| Envestnet Asset Management Inc | 0 | $0 | 0.00% | −11,454−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| New York State Common Retirement Fund | 0 | $0 | 0.00% | −6,630−100.0% | Sold out |